US Stock MarketDetailed Quotes

YMAB Y-mAbs Therapeutics

Watchlist
  • 4.500
  • +0.070+1.58%
Close Apr 1 16:00 ET
  • 4.500
  • 0.0000.00%
Post 16:05 ET
203.48MMarket Cap-6.72P/E (TTM)

Y-mAbs Therapeutics Key Stats

Business Currency:USD
2024/FY
Stock NameRevenueRatio
Product revenue, net85.19M97.15%
License revenue2.5M2.85%
Region Currency:USD
2024/FY
Stock NameRevenueRatio
United States65.98M75.25%
Eastern Asia7.46M8.50%
Latin America4.72M5.38%
Western Asia4.05M4.62%
License revenue2.5M2.85%
Western Europe2.09M2.38%
Other regions890K1.01%
View all

Market Insights

Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

Unlock Now

Discussing

Chinese stock earnings surge: Will profit sustain the rally?
1. Which sectors are likely to be market highlights this season? 2. With the government's emphasis on technological innovation and sustaina Show More